Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP679751.RA80aPwTh5nBEZkJxBA09drmGvlTLSuOWBoY1gpsA9oOQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP679751.RA80aPwTh5nBEZkJxBA09drmGvlTLSuOWBoY1gpsA9oOQ130_assertion type Assertion NP679751.RA80aPwTh5nBEZkJxBA09drmGvlTLSuOWBoY1gpsA9oOQ130_head.
- NP679751.RA80aPwTh5nBEZkJxBA09drmGvlTLSuOWBoY1gpsA9oOQ130_assertion description "[Aberrant methylation of TFPI-2 was also detected in 73% (102/140) of pancreatic cancer xenografts and primary pancreatic adenocarcinomas, was more likely in older patients with pancreatic cancer, and significantly correlated with progression of IPMNs (P=0.0002).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP679751.RA80aPwTh5nBEZkJxBA09drmGvlTLSuOWBoY1gpsA9oOQ130_provenance.
- NP679751.RA80aPwTh5nBEZkJxBA09drmGvlTLSuOWBoY1gpsA9oOQ130_assertion evidence source_evidence_literature NP679751.RA80aPwTh5nBEZkJxBA09drmGvlTLSuOWBoY1gpsA9oOQ130_provenance.
- NP679751.RA80aPwTh5nBEZkJxBA09drmGvlTLSuOWBoY1gpsA9oOQ130_assertion SIO_000772 15592528 NP679751.RA80aPwTh5nBEZkJxBA09drmGvlTLSuOWBoY1gpsA9oOQ130_provenance.
- NP679751.RA80aPwTh5nBEZkJxBA09drmGvlTLSuOWBoY1gpsA9oOQ130_assertion wasDerivedFrom befree-20140225 NP679751.RA80aPwTh5nBEZkJxBA09drmGvlTLSuOWBoY1gpsA9oOQ130_provenance.
- NP679751.RA80aPwTh5nBEZkJxBA09drmGvlTLSuOWBoY1gpsA9oOQ130_assertion wasGeneratedBy ECO_0000203 NP679751.RA80aPwTh5nBEZkJxBA09drmGvlTLSuOWBoY1gpsA9oOQ130_provenance.